Ishami ry'Umuryango w'Abibumbye ryita ku Buzima (OMS) ryatangaje uyu munsi ko GlaxoSmithKline (GSK) izongera inshingano zayo zo gutanga ibiyobyabwenge byangiza albendazole kugeza igihe isi yose izakuraho indwara ya lymphatic filariasis nk'ikibazo cy'ubuzima rusange. Byongeye kandi, mu 2025, miliyoni 200 buri mwaka ibinini byo kuvura indwara zandurira mu mibonano mpuzabitsina bizatangwa, naho mu 2025, ibinini miliyoni 5 ku mwaka byo kuvura indwara ya echinococcose.
Iri tangazo riheruka gushingira ku masezerano y’isosiyete imaze imyaka 23 yo kurwanya indwara eshatu zita ku turere dushyuha (NTDs) zirimo gufata nabi cyane bamwe mu baturage bakennye cyane ku isi.
Iyi mihigo ni imwe mu mihigo ishimishije yakozwe na GSK uyu munsi mu nama ya Malariya na Indwara Y’ubushyuhe bwo mu Tropical Diseases yabereye i Kigali, aho batangaje ishoramari rya miliyari imwe mu myaka 10 yo kwihutisha iterambere ry’indwara zanduza. - ibihugu byinjiza. Itangazo rigenewe abanyamakuru).
Ubushakashatsi buzibanda ku miti n’inkingo nshya zagezweho mu rwego rwo kwirinda no kuvura malariya, igituntu, virusi itera sida (binyuze mu buzima bwa ViiV) ndetse n’indwara zita ku turere dushyuha, kandi ikanakemura ibibazo birwanya mikorobe, bikomeje kwibasira abaturage bugarijwe n'ibibazo kandi bigatera impfu nyinshi. . Umutwaro w'indwara mu bihugu byinshi byinjiza amafaranga arenga 60%.